Literature DB >> 11427411

Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.

C T Tiemessen1, S Shalekoff, S Meddows-Taylor, D J Martin.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11427411      PMCID: PMC96127          DOI: 10.1128/CDLI.8.4.686-689.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


× No keyword cloud information.
  22 in total

1.  Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.

Authors:  B Moser; C Schumacher; V von Tscharner; I Clark-Lewis; M Baggiolini
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis.

Authors:  S Antonaci; E Jirillo; A Polignano; M T Ventura; R Sabato; L Bonomo
Journal:  Cytobios       Date:  1991

3.  Immunoprofile studies in patients with pulmonary tuberculosis. IV. Tuberculin skin reaction and test of inhibition of blood leukcoyte migration.

Authors:  M Rieger; L Trnka; J Skvor
Journal:  Scand J Respir Dis       Date:  1979-12

4.  Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Authors:  S Z Wiktor; M Sassan-Morokro; A D Grant; L Abouya; J M Karon; C Maurice; G Djomand; A Ackah; K Domoua; A Kadio; A Yapi; P Combe; O Tossou; T H Roels; E M Lackritz; D Coulibaly; K M De Cock; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

5.  Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.

Authors:  S D Lawn; R J Shattock; J W Acheampong; R B Lal; T M Folks; G E Griffin; S T Butera
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

6.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

7.  The chemotactic receptor for human C5a anaphylatoxin.

Authors:  N P Gerard; C Gerard
Journal:  Nature       Date:  1991-02-14       Impact factor: 49.962

8.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor.

Authors:  P M Murphy; H L Tiffany
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

9.  High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.

Authors:  C Schumacher; I Clark-Lewis; M Baggiolini; B Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.

Authors:  W D Hardy; J Feinberg; D M Finkelstein; M E Power; W He; C Kaczka; P T Frame; M Holmes; H Waskin; R J Fass
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

View more
  3 in total

1.  Tubo-ovarian mass with raised CA-125 in a 21-year-old female.

Authors:  Roli Purwar; Kishan Soni; Ragini Tilak; Ashish Verma; Manoj Pandey
Journal:  World J Surg Oncol       Date:  2022-06-08       Impact factor: 3.253

2.  Disseminated Nocardiosis in renal transplant recipient under therapy for pulmonary tuberculosis: a case report.

Authors:  Priyatam Khadka; Ramesh Bahadur Basnet; Pratap Khadka; Dibya Singh Shah; Bharat Mani Pokhrel; Basista Parsad Rijal; Jeevan Bahadur Sherchand
Journal:  BMC Res Notes       Date:  2017-02-03

3.  Primary cutaneous nocardiosis: a diagnosis of consideration in a renal transplant recipient.

Authors:  Priyatam Khadka; Dibya Singh Shah
Journal:  BMC Clin Pathol       Date:  2018-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.